Newsbenzinga
Zhengye Biotechnology Says It Received Nasdaq Letter Confirming Regained Compliance With $1.00 Minimum Bid Price Requirement
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…